Ticker ALVR – Allovir – sales, description, marketcap – Tickerday.com

ALVR

Allovir

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 2.03B; Volume: 955.91K; AvgVol 3m: 588.82K; Beta: ;

Cost estimate:

P/E: ; EPS: -0.44; EPS growth quarter/prev quarter: ;

EPS growth this year: -192.30%; EPS growth past 5 years: ;

EPS ttm: -0.44;

P/S: ; P/B: ; P/Cashflow: 16.82; P/FCF: ;

Sales: 170.00K; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: ; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 36.40%; Insider Transactions:14.17%;

Institutional Ownership: ; Institutional Transactions: ;

Data update: 07.10.2020.

Leave a comment

Your email address will not be published. Required fields are marked *